PRO MEDICUS LIMITED — Director's Dealing 2020

Mar 17, 2020

Appendix 3Y Change of Director’s Interest Notice

Listing Rule 3.19A.2

Appendix 3Y

Change of Director’s Interest Notice

Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX’s property and may be made public.

Introduced 30/9/2001.

Name of entity Pro Medicus Limited ABN 25 006 194 752

We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for the director for the purposes of section 205G of the Corporations Act.

Name of DirectorDate of last notice	Sam Aaron HUPERT6 September 2019

Part 1 - Change of director’s relevant interests in securities

In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust

Note: In the case of a company, interests which come within paragraph (i) of the definition of “notifiable interest of a director” should be disclosed in this part.

Direct or indirect interest	Direct
Nature of indirect interest(including registered holder)Note: Provide details of the circumstances giving rise to the relevantinterest.	Ordinary fully paid shares in Pro MedicusLimited held by Sam Aaron HUPERT
Date of change	13 March 202016 March 202017 March 2020
No. of securities held prior to change	28,107,660 ordinary shares consisting off:-•28,072,660 ordinary shares heldunder Sam Aaron HUPERT•35,000 ordinary shares held underAlltogether Superannuation Fund
Class	Ordinary shares
Number acquired	13 March 2020 – 5,000 ordinary shares16 March 2020 – 18,510 ordinary shares17 March 2020 – 6,490 ordinary sharesAll purchased by Alltogether SuperannuationFund

• See chapter 19 for defined terms.

Appendix 3Y Page 1

11/3/2002

Appendix 3Y Change of Director’s Interest Notice

Number disposed	Nil
Value/ConsiderationNote: If consideration is non-cash, provide details and estimated valuation	13 March 2020 – $15.50 per share16 March 2020 – $15.635062 per share17 March 2020 – $15.48 per share
No. of securities held after change	28,137,660 ordinary shares consisting off:-•28,072,660 ordinary shares heldunder Sam Aaron HUPERT•65,000 ordinary shares held underAlltogether Superannuation Fund
Nature of changeExample: on-market trade, off-market trade, exercise of options, issue ofsecurities under dividend reinvestment plan, participation in buy-back	On market trade

Part 2 – Change of director’s interests in contracts

Note: In the case of a company, interests which come within paragraph (ii) of the definition of “notifiable interest of a director” should be disclosed in this part.

Detail of contract	N/A
Nature of interest	N/A
Name of registered holder(if issued securities)	N/A
Date of change	N/A
No. and class of securities to whichinterest related prior to changeNote: Details are only required for a contract in relationto which the interest has changed	N/A
Interest acquired	N/A
Interest disposed	N/A
Value/ConsiderationNote: If consideration is non-cash, provide details and anestimated valuation	N/A
Interest after change	N/A

• See chapter 19 for defined terms.

Appendix 3Y Page 2

11/3/2002

Appendix 3Y Change of Director’s Interest Notice

Part 3 –[+] Closed period

Were the interests in the securities or contracts detailedabove traded during a+closed period where prior writtenclearance was required?	No
If so, was prior written clearance provided to allow thetrade to proceed during this period?	N/A
If prior written clearance was provided, on what date wasthis provided?	N/A

For and on behalf of Pro Medicus Limited

==> picture [133 x 63] intentionally omitted <==

Clayton Hatch Company Secretary 18 March 2020

• See chapter 19 for defined terms.

Appendix 3Y Page 3

11/3/2002